Mosaic software to manage new biological entity samples
Sample management software provider Titian Software has announced that Boehringer Ingelheim has implemented the company’s Mosaic sample management software for the inventory management, sample tracking and sample processing of new biological entities (NBE).
As a provider of sample management software for small molecule compound libraries, Titian has evolved Mosaic into enterprise-wide management of biological samples, reagents and standards. The new installation has Boehringer Ingelheim incorporating Mosaic into its protein purification, gene expression, biological lead engineering and biological lead generation workflows within the NBE groups.
Titian CEO Edmund Wilson said: “Drug discovery is now more challenging than ever, and so pharmaceutical, biotech and academic organisations are seeking to maximise the efficiencies of their laboratory processes. Knowing where a sample is, what its character make-up is and what has been done to it and by whom is an essential element in this efficiency.
“Mosaic’s success has been built on the premise of listening to the needs of customers in various organisations. Based on this, we have developed Mosaic to cover biological applications in addition to our heartland of chemical sample management, for which we are recognised as the ‘go-to’ offering.
“We are delighted to announce this project with Boehringer Ingelheim, which reflects Mosaic’s success with the management of biological samples.”
Mosaic is a modular software suite providing a range of flexible options for many different types and sizes of life science research organisations in industry and academia.
How AI-enabled embedded modules are advancing medtech
AI has been a longstanding focus in medical technology, predating its adoption in other...
Veterinary LIMS improves laboratory efficiency
The North Dakota State University Veterinary Diagnostic Laboratory has significantly benefited...
AI tool enables rapid and cost-effective drug discovery
The Australian-invented AI tool has the potential to reshape virtual screening in early-stage...